Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 6/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.39 |
| ▸ | HTR2A | P28223 | 6/20 | 0.39 |
| ▸ | ITK | Q08881 | 1/20 | 0.36 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | PLK1 | P53350 | 2/20 | 0.35 |
| ▸ | FADS1 | O60427 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31411318 | 0.86 | MPO (0.55) | MPOSLC6A4HTR2AITKHTR2C | |
| SCHEMBL31411381 | 0.82 | HTR2A (0.58) | MPOSLC6A4HTR2AITKHTR2C | |
| SCHEMBL25249523 | 0.82 | HTR2A (0.46) | SLC6A4HTR2AHTR2CFADS1 | |
| SCHEMBL31411392 | 0.81 | GPR84 (0.33) | — | |
| Hydrochloric Acid SCHEMBL30565940 | 0.81 | HTR2A (0.45) | SLC6A4HTR2AHTR2CFADS1 | |
| SCHEMBL31411348 | 0.79 | SLC6A4 (0.42) | MPOSLC6A4HTR2A | |
| SCHEMBL31411350 | 0.77 | HTR1A (0.45) | — | |
| SCHEMBL27751008 | 0.75 | MPO (0.41) | MPOSLC6A4HTR2AITKPLK1 | |
| SCHEMBL10271562 | 0.75 | ITK (0.43) | MPOHTR2AITKPLK1FADS1 | |
| SCHEMBL24693767 | 0.74 | MPO (0.74) | MPOSLC6A4HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735425-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2026-05-06 | — | — | EP | disclosed |
| US-20250353818-A1 | Compounds | Psylo Pty Ltd (AU) | 2025-11-20 | — | — | US | disclosed |
| US-12428380-B2 | Compounds | Psylo Pty Ltd (AU) | 2025-09-30 | — | — | US | disclosed |
| US-20250214943-A1 | Compounds | Psylo Pty Ltd (AU) | 2025-07-03 | — | — | US | disclosed |
| WO-2025000053-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-01-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214943-A1 | Compounds | NLN, SLC18A2, PYGB | MPO 559/4885SLC6A4 18/4885HTR2A 94/4885 |
| US-12428380-B2 | Compounds | NLN, SLC18A2, PYGB | MPO 559/4885SLC6A4 18/4885HTR2A 94/4885 |
| US-20250353818-A1 | Compounds | NLN, SLC18A2, PYGB | MPO 559/4885SLC6A4 18/4885HTR2A 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.